Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Exercise and Pioglitazone for HIV-Metabolic Syndromes [NA]
A completed clinical trial from NIDDK examining the combination of exercise and pioglitazone for HIV-associated metabolic syndromes, with re…
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes [Phase 4]
A Phase 4 trial comparing patient-adjusted dosing of biphasic insulin aspart 30 with physician-adjusted dosing, both given with metformin, i…
-
FDA approval · 2013-09-11FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approves Westminster Pharmaceuticals' original application for metformin hydrochloride, a generic version of the diabetes medication.
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment [Phase 1]
Phase 1 study evaluating the pharmacodynamic and pharmacokinetic effects of LX4211 in subjects with Type 2 Diabetes Mellitus and renal impai…
-
FDA approval · 2013-09-06FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by Sanofi-Aventis U.S. LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-09-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, expanding the regulatory approval for the product.
-
CLINICAL_TRIALS withdrawal · 2013-09-06Clinical Trial Update: Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes [NA]
A clinical trial studying the effect of atorvastatin on vascular inflammation in type 2 diabetes patients has been withdrawn. The sponsor li…
-
CLINICAL_TRIALS research · 2013-09-06Clinical Trial Update: Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana
A multicenter study to build a repository for researching chronic diseases in Indiana, including type 2 diabetes mellitus.
-
FDA approval · 2013-09-05FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO (linagliptin/metformin hydrochloride) from Boehringer Ingelheim, resulting in a label…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Sleep Loss and Energy Metabolism in People With Family History of Type 2 Diabetes. [NA]
This completed clinical trial from the University of Chicago examined how sleep loss affects energy metabolism and insulin resistance in peo…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Sleep Disordered Breathing and Diabetes
The clinical trial examining sleep disordered breathing in people with Type 2 diabetes mellitus and obstructive sleep apnea has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Glucose Metabolism and Sleep in People With Family History of Type 2 Diabetes.
A completed University of Chicago study investigates how sleep affects glucose metabolism and insulin resistance in people with a family his…
-
CLINICAL_TRIALS research · 2013-09-05Clinical Trial Update: Fitness and Sleep in People With Family History of Type 2 Diabetes.
A completed clinical trial assessing how fitness and sleep relate to diabetes risk in individuals with a family history of type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: REACH-OUT: Chicago Children's Diabetes Prevention Program [NA]
The REACH-OUT Chicago Children's Diabetes Prevention Program trial has completed; the update does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Sleep Loss and Glucose Metabolism in People With Family History of Type 2 Diabetes. [NA]
Clinical trial completed assessing how sleep loss affects glucose metabolism in people with a family history of type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of JNJ-38431055, sitagliptin, an…
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins [Phase 4]
A Phase 4 clinical trial assesses whether thiazolidinedione drugs (glitazones) influence HDL-mediated vasodilation in individuals with type …
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units [NA]
Clinical trial evaluating a 4mm x 32G pen needle for higher basal insulin doses in type 2 diabetes was terminated; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus [Phase 3]
This update reports the results of a Phase 3 trial evaluating vildagliptin 50 mg twice daily as add-on therapy to insulin (with or without m…
-
CLINICAL_TRIALS research · 2013-08-30Clinical Trial Update: The SMART-ORACLE Study
The SMART-ORACLE study, sponsored by UMC Utrecht, has an update on ClinicalTrials.gov. The listed conditions include coronary artery disease…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 trial evaluating 24 weeks of Vildagliptin in patients with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: Hypoglycemic Effects of Fermented Red Ginseng in Subject With Impaired Fasting Glucose or Type 2 Diabetes [Phase 2, Phase 3]
A Phase 2/3 study evaluating the hypoglycemic effects of fermented red ginseng in individuals with impaired fasting glucose or Type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes [Phase 1]
Pfizer reported results from a Phase 1 trial of PF-04991532 in adults with Type 2 diabetes; the study is completed and results were posted i…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet [Phase 1]
A Phase 1 crossover bioequivalence study comparing Glucobay orally disintegrating tablet to Glucobay standard tablet (acarbose) for Type 2 d…
-
CLINICAL_TRIALS trial_result · 2013-08-27Clinical Trial Update: CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
A completed clinical trial evaluating continuous glucose monitoring (CGM) to characterize glucose excursions in basal insulin–treated type 2…